Therapeutic potential of adult platelets and cord blood platelets in future clinical directions

Bezawada SR, Velluri V, Darapuneni RC

Pdf Page Numbers :- 347-353

Srinivasa Rao Bezawada^1,*, Vaishnavi Velluri¹ and Radhika Chowdary Darapuneni^1,2

¹KIMS Foundation and Research Centre, Minister Road, Secunderabad - 500003, Telangana, India

²Department Laboratory Medicine, Krishna Institute of Medical Sciences, Minister Road, Secunderabad-500003, Telangana, India

*Corresponding author: Dr. Srinivasa Rao Bezawada, M.Sc., Ph.D., Scientist, KIMS Foundation and Research Centre, Minister Road, Secunderabad - 500003, Telangana, India. Email: srinumicros@yahoo.co.in

Received 9 August 2023; Revised 11 September 2023; Accepted 19 September 2023; Published 30 September 2023

Citation: Bezawada SR, Velluri V, Darapuneni RC. Therapeutic potential of adult platelets and cord blood platelets in future clinical directions. J Med Sci Res. 2023; 11(4):347-353. DOI: http://dx.doi.org/10.17727/JMSR.2023/11-63

Copyright: © 2023 Bezawada SR et al. Published by KIMS Foundation and Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PDF

Abstract

Platelet rich plasma (PRP) is currently obtaining a natural concentration of autologous growth factors, and is used in different medical conditions. This review is aimed to establish several treatment options using adult PRP and scope of the therapeutic benefits of cord blood platelet rich plasma (CB-PRP) for future clinical directions. A literature search was done based on the clinical applications of PRP in the fields of dermatology, orthopaedic, dental, ophthalmology and gynaecology. The field keywords were searched in major indexing services for collecting the relevant articles from January 2010 to June 2023. PRP therapies are potential and efficient treatment options and established protocols for certain diseases but there is a need to establish CB-PRP opportunities of improving efficacy for promoting clinical application. Further research can focus on CB-PRP and it may be considered as immunologically compatible to use as allogenic.

Keywords: platelet rich plasma; therapy; cord blood PRP; hair loss; poor ovarian reserve; osteoarthritis